Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Freezing breast tumors: a gentler option for seniors?

NCT ID NCT07398118

First seen Feb 17, 2026 · Last updated Jun 23, 2026 · Updated 22 times

Summary

This study tests a procedure called cryoablation, which freezes and destroys small breast tumors, as a possible alternative to surgery or hormone therapy for people aged 70 and older with early-stage breast cancer. The goal is to see if the treatment is safe and practical. Researchers will track side effects, recovery, and whether additional treatment is needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Amphia Hospital

    Breda, North Brabant, 4818 CK, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Antoni van Leeuwenhoek - Nederlands Kanker Instituut

    Amsterdam, North Holland, 1066 CX, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Rijnstate Hospital

    Arnhem, Gelderland, 6836 BH, Netherlands

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cryoablation (freezing procedure)

What this could lead to

If successful, this could offer older adults with early-stage breast cancer a less invasive treatment option that avoids surgery and long-term hormone therapy.

What could go wrong

This is a small, early feasibility study (61 participants) with no control group. The procedure may not fully destroy the tumor, and long-term cancer control is not yet proven.

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.